Camlin Fine Sciences Ltd. Share Price

announced Q1FY27 results Consolidated Financial Highlights:

announced Q1FY27 results Consolidated Financial Highlights: Revenue from Operations: The consolidated revenue from operations for Q1FY27 stood at Rs 5,198.79 million, representing a growth of 27.51% YoY from Rs 4,077.21 million in Q1FY26 and an increase of 22.38% QoQ from Rs 4,248.11 million in Q4FY26. Total Income: Total income for the quarter reached Rs 5,212.19 million in Q1FY27, compared to Rs 4,143.48 million in Q1FY26 and Rs 4,487.23 million in Q4FY26. Net Profit/(Loss): The group reported a consolidated net loss for the period of Rs 336.22 million in Q1FY27, as against a net profit of Rs 862.77 million in Q4FY26 and a net loss of Rs 106.81 million in Q1FY26. Total Comprehensive Income: Total comprehensive loss for Q1FY27 was Rs 163.62 million, compared to a comprehensive income of Rs 12.48 million in Q1FY26 and Rs 743.85 million in Q4FY26.

See More

🧪 Camlin Fine Sciences: Cup & Handle Breakout Points Toward a Fresh Uptrend

📈 Technical View 1. Elliott Wave Structure The decline from previous highs appears to have completed a larger corrective phase. The rounded cup formation suggests the development of a new impulsive cycle, with the recent breakout indicating the start of a potential Wave-3 advance. Historically, Wave-3 tends to be the strongest leg of the trend and can generate substantial price appreciation once resistance is cleared. 2. MACD Bullish Divergence During the formation of the cup bottom, prices created lower lows while momentum gradually improved. This positive divergence signaled that bearish momentum was weakening despite continued price pressure. The subsequent breakout above resistance validates the shift in momentum from sellers to buyers. 3. AVWAP Indicates Institutional Accumulation The Anchored VWAP from the major swing low has been steadily rising and acted as support during multiple pullbacks. Price reclaiming and sustaining above AVWAP suggests accumulation by stronger market participants. As long as the stock remains above this value area, the bullish setup remains favorable. 🏢 Fundamental Strength The technical breakout is supported by improving business fundamentals: ✅ Established global presence in specialty chemicals and performance ingredients. ✅ Strong positioning in antioxidant and shelf-life extension solutions. ✅ Improving operating margins through efficiency initiatives. ✅ Healthy long-term demand outlook driven by food, feed, and industrial applications. ✅ Potential earnings growth supported by capacity utilization improvements. 🎯 Key Levels to Watch Breakout Zone: ₹139–140 Immediate Support: ₹135–139 Projected Upside Target: ₹180–185 (based on Cup & Handle measurement) Risk Management: Sustained trading below the breakout zone could delay the bullish thesis.

See More

Camlin Fine Sciences Promoter Creates Additional Share Pledge Worth ₹15.29 Crore

Camlin Fine Sciences promoter Ashish S. Dandekar has pledged an additional 13.25 lakh shares worth ₹15.29 crore through two transactions in March 2026. The pledges, created on March 20 and March 25, serve as additional margin for financial assistance arrangements. Post these transactions, 74.07% of Dandekar's total promoter holding of 1.98 crore shares (10.30% of company's capital) is now encumbered.

See More

These 24 Stocks are on 20% Upper Circuit today. Explosive momentum in Small & Midcaps. Faze Three Sirohia & Sons Avanti Feeds Garware Hi Tech Gokaldas Exports Goldiam Intl Pokarna Avalon Tech Oriana Power Sh. Jagdamba Pol Waterbase Magna Electrocas Kanpur Plastipa. ADF Foods Camlin Fine Indo Count Ind Nelcast Precot Kitex Garments Apex Frozen Food Paramount Comm. Innovative Ideal Kabsons Ind Breadth strong with 235+ UCs overall.

See More

Camlin Fine Sciences – Retest of Breakdown Zone With RSI Near Oversold Levels

1. Prior Resistance Turning Into Support Zone Price has corrected back toward a key historical resistance area, which is now being tested as a potential support. This zone has previously acted as a supply area, and the current retest will decide whether it can successfully flip into demand. 2. Trendline Interaction After Sharp Rally After a strong vertical rally, the stock has cooled off and moved back toward the falling trendline zone. Such pullbacks after sharp up-moves are structurally healthy, provided price stabilizes around key levels. 3. RSI Near Oversold Territory RSI has cooled significantly from overbought levels and is now approaching the lower band. This suggests selling pressure is easing and the stock may be closer to a stabilization phase rather than continuation of aggressive downside. 4. Momentum Reset in Progress The prior rally led to stretched momentum, and the current correction appears to be a reset phase. A sideways-to-range movement near this support could help rebuild momentum for the next directional move. 5. Key Observations Pullback toward prior resistance-turned-support RSI nearing oversold, indicating exhaustion in selling Structural support test in progress Market likely awaiting confirmation through price stability and volume behavior Overall, the chart reflects a pullback into an important decision zone, where stabilization would be constructive, while failure to hold may invite further consolidation. 📢 Disclaimer: For educational and technical analysis purposes only; not investment advice. 👤 Rajneesh Sharma – SEBI Registered Research Analyst (INH000020332)

See More

Camlin Fine Sciences Specialty Chemicals with Global Exposure

Camlin Fine Sciences operates in the specialty chemicals space, supplying ingredients used in food, animal nutrition and industrial applications. The company benefits from diversified end-markets and a global customer base, which helps reduce dependence on any single geography. However, margins are sensitive to raw material prices, energy costs and demand conditions. Performance is also influenced by regulatory requirements and competitive intensity in specialty chemicals. Monitoring cost control, capacity utilization and export demand remains important. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes ***** must verify information before investing and consider their financial position & risk profile. please read full disclosure disclaimer in given link

See More